capsensixx AG carries a market capitalization of 51.29M, placing it among publicly traded companies globally. Its enterprise value stands at -8.56M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 51.29M |
| Enterprise Value | -8.56M |
capsensixx AG currently has 3.09M shares outstanding.
| Shares Outstanding | 3.09M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
capsensixx AG maintains a current ratio of 2.52, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 21.38, indicating elevated leverage, while an interest coverage ratio of 101.76 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.52 |
| Quick Ratio | 1.63 |
| Debt / Equity | 21.38 |
| Debt / EBITDA | 0.60 |
| Interest Coverage | 101.76 |
capsensixx AG posts a return on equity of 21.21 and a return on invested capital of 21.09.
| Return on Equity (ROE) | 21.21 |
| Return on Assets (ROA) | 3.94 |
| Return on Invested Capital (ROIC) | 21.09 |
| Return on Capital Employed (ROCE) | -1.32 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, capsensixx AG has paid 2.51M in income taxes, reflecting an effective tax rate of 29.04.
| Income Tax | 2.51M |
| Effective Tax Rate | 29.04 |
capsensixx AG's stock has gained approximately 1.21951% over the past 52 weeks. The 50-day moving average sits at 16.63, while the 200-day moving average is 16.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1.21951% |
| 50-Day Moving Average | 16.63 |
| 200-Day Moving Average | 16.19 |
| Average Volume (20 Days) | N/A |
EBITDA reached 8.75M, while operating income came in at 8.75M.
| Revenue | 119.75M |
| Gross Profit | 17.99M |
| Operating Income | 8.75M |
| Pretax Income | 8.63M |
| Net Income | 2.85M |
| EBITDA | 8.75M |
| EBIT | 8.75M |
| Earnings Per Share (EPS) | N/A |
capsensixx AG holds 23.70M in cash and equivalents against 5.29M in total debt, resulting in a net debt position of -18.46M. Total book value stands at 14.83M, with working capital of 22.14M providing operational flexibility.
| Cash & Cash Equivalents | 23.70M |
| Total Debt | 5.29M |
| Net Debt | -18.46M |
| Equity (Book Value) | 14.83M |
| Book Value Per Share | N/A |
| Working Capital | 22.14M |
capsensixx AG operates with a gross margin of 15.02, reflecting its pricing power and cost economics. The operating margin of 7.31 and net profit margin of 2.38 provide insight into operational efficiency.
| Gross Margin | 15.02 |
| Operating Margin | 7.31 |
| Pretax Margin | 7.20 |
| Profit Margin | 2.38 |
| EBITDA Margin | 7.31 |
capsensixx AG posts an Altman Z-Score of 4.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.48 |